72 related articles for article (PubMed ID: 19856117)
21. Reproductive factors and breast cancer risk among older women.
Shantakumar S; Terry MB; Teitelbaum SL; Britton JA; Millikan RC; Moorman PG; Neugut AI; Gammon MD
Breast Cancer Res Treat; 2007 May; 102(3):365-74. PubMed ID: 17033925
[TBL] [Abstract][Full Text] [Related]
22. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
[TBL] [Abstract][Full Text] [Related]
23. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
Cummings SR; Lee JS; Lui LY; Stone K; Ljung BM; Cauleys JA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1047-51. PubMed ID: 15894651
[TBL] [Abstract][Full Text] [Related]
24. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.
Helzlsouer KJ; Gordon GB; Alberg AJ; Bush TL; Comstock GW
Cancer Res; 1992 Jan; 52(1):1-4. PubMed ID: 1530765
[TBL] [Abstract][Full Text] [Related]
25. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
[TBL] [Abstract][Full Text] [Related]
27. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
28. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer.
Wu K; Helzlsouer KJ; Comstock GW; Hoffman SC; Nadeau MR; Selhub J
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):209-17. PubMed ID: 10090298
[TBL] [Abstract][Full Text] [Related]
29. Early-life physical activity and postmenopausal breast cancer: effect of body size and weight change.
Shoff SM; Newcomb PA; Trentham-Dietz A; Remington PL; Mittendorf R; Greenberg ER; Willett WC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):591-5. PubMed ID: 10868694
[TBL] [Abstract][Full Text] [Related]
30. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
31. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk and the combined effect of environmental estrogens.
Ibarluzea Jm Jm; Fernández MF; Santa-Marina L; Olea-Serrano MF; Rivas AM; Aurrekoetxea JJ; Expósito J; Lorenzo M; Torné P; Villalobos M; Pedraza V; Sasco AJ; Olea N
Cancer Causes Control; 2004 Aug; 15(6):591-600. PubMed ID: 15280638
[TBL] [Abstract][Full Text] [Related]
33. Serum calcium and tumour aggressiveness in breast cancer: a prospective study of 7847 women.
Almquist M; Anagnostaki L; Bondeson L; Bondeson AG; Borgquist S; Landberg G; Malina J; Malm J; Manjer J
Eur J Cancer Prev; 2009 Sep; 18(5):354-60. PubMed ID: 19593149
[TBL] [Abstract][Full Text] [Related]
34. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters.
Dalamaga M; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
Clin Biochem; 2013 May; 46(7-8):584-90. PubMed ID: 23321342
[TBL] [Abstract][Full Text] [Related]
35. Serum 'Vitamin-Mineral' Profiles: Associations with Postmenopausal Breast Cancer Risk Including Dietary Patterns and Supplementation. A Case-Control Study.
Krusinska B; Wadolowska L; Biernacki M; Slowinska MA; Drozdowski M
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31540424
[TBL] [Abstract][Full Text] [Related]
36. Serum calcium, tumor size, and hormone receptor status in women with untreated breast cancer.
Thaw SS; Sahmoun A; Schwartz GG
Cancer Biol Ther; 2012 May; 13(7):467-71. PubMed ID: 22406994
[TBL] [Abstract][Full Text] [Related]
37. Is There Any Role for Serum Cathepsin S and CRP Levels on Prognostic Information in Breast Cancer? The Swedish Mammography Cohort.
Basu S; Harris H; Larsson A; Vasson MP; Wolk A
Antioxid Redox Signal; 2015 Dec; 23(16):1298-302. PubMed ID: 26079659
[TBL] [Abstract][Full Text] [Related]
38. Selenium in breast cancer.
Lopez-Saez JB; Senra-Varela A; Pousa-Estevez L
Oncology; 2003; 64(3):227-31. PubMed ID: 12697962
[TBL] [Abstract][Full Text] [Related]
39. Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies.
Wulaningsih W; Sagoo HK; Hamza M; Melvin J; Holmberg L; Garmo H; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608013
[TBL] [Abstract][Full Text] [Related]
40. Does a higher ratio of serum calcium to magnesium increase the risk for postmenopausal breast cancer?
Sahmoun AE; Singh BB
Med Hypotheses; 2010 Sep; 75(3):315-8. PubMed ID: 20371155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
